SP1 and chronic myelogenous leukemia, BCR-ABL1 positive: We demonstrated that silencing Sp1 by dnSp1 increases sensitivity of CML cells to niclosamide, whereas overexpression of Sp1 attenuated apoptosis induced by niclosamide.